title: Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 2: new immune paradigm.
abstract: Alzheimer's disease (AD) is the most common form of dementia. Its most important pathological hallmarks are profound neuronal loss, presence of intracellular neurofibrillary tangles, and extracellular deposition of beta-amyloid protein (Aβ) as beta-amyloid plaques. One of the most important risk factors for AD is age and with the increase of life-expectancy AD has become the most common form of dementia. The current "Holy Grail" is to be able to diagnose variants of AD before they manifest clinically and before irreparable brain damage is done. To be able to do so, we need robust and reliable biomarkers which reflect the pathogenesis of AD. This is essential because such biomarkers might indicate pathways that could be targeted for interventions aiming at disease prevention or amelioration. Although much attention has been focused on Aβ in this respect, it may not be as attractive a target as thought if current doubts concerning its causative role are substantiated. This review will be in two parts, the first part dealt with the current clinical knowledge and the questions raised by the Aβ cascade hypothesis in the pathogenesis of AD and this second part aims to synthesize our current knowledge and new data suggesting how immunity may contribute to the development of AD and may itself be targeted in future treatments.
authors: Research Center on Aging, University of Sherbrooke, Sherbrooke, Quebec J1H 4C4, Canada. tamas.fulop@usherbrooke.ca
authors: Tamas
authors: T
authors: Fulop
authors: Guy
authors: G
authors: Lacombe
authors: Stephen
authors: S
authors: Cunnane
authors: Aurélie
authors: A
authors: Le Page
authors: Gilles
authors: G
authors: Dupuis
authors: Eric H
authors: EH
authors: Frost
authors: Karine
authors: K
authors: Bourgade-Navarro
authors: David
authors: D
authors: Goldeck
authors: Anis
authors: A
authors: Larbi
authors: Graham
authors: G
authors: Pawelec
mesh_terms: D000544:Alzheimer Disease / Q000276:immunology* / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D006801:Humans; D008954:Models, Biological
chemical_list: D016229:Amyloid beta-Peptides; D015415:Biomarkers